206 results
Page 4 of 11
8-K
EX-4.4
ueuirk dkw84mr
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
8-K
EX-1.1
q932m 79p70
23 Jan 13
Theravance Announces Pricing of Convertible Subordinated
12:00am
424B5
xvtvv0a
18 Jan 13
Prospectus supplement for primary offering
12:00am
S-3ASR
e7tmnnlg8lfzy
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-1.1
phdbm7 k2hrz
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-5.1
9ylef7o58 r3t
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-4.4
fwkoqazzmn6i0g2
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-5.2
ccrjtbas1
16 Jan 13
Automatic shelf registration
12:00am
8-K
EX-10.1
f2r1a wxi
2 Apr 12
GlaxoSmithKline to increase its ownership in Theravance
12:00am